Developing improved therapies for cytomegalovirus infections by overcoming viral strain diversity.

通过克服病毒株多样性，开发针对巨细胞病毒感染的改进疗法。

• 批准号: nhmrc : 2004397
• 金额: $ 112.68万
• 依托单位国家: 澳大利亚
• 项目类别: Ideas Grants
• 财政年份: 2021
• 资助国家: 澳大利亚
• 起止时间: 2021-01-01 至 2024-12-31
• 项目状态: 已结题
• 来源: https://researchdata.edu.au/developing-improved-therapies-strain-diversity/1780350
• 关键词: Developing; improved; therapies; cytomegalovirus; infections

Cytomegalovirus infection is the most common cause of infection-related disease in newborns and is one of the most common complications in transplant patients. Current treatments are not always successful and are associated with significant side-effects. We have therefore developed world first systems that can be used to develop safer, more effective treatments for this life-threatening infection. Our findings are likely to be applicable to other difficult to manage viral infections.

巨细胞病毒感染是新生儿感染相关疾病的最常见原因，也是移植患者最常见的并发症之一。目前的治疗并不总是成功的，并与显着的副作用。因此，我们开发了世界上第一个系统，可用于开发更安全，更有效的治疗这种危及生命的感染。我们的发现可能适用于其他难以管理的病毒感染。